Pamidronate: Treatment for severe hypercalcemia in neonatal subcutaneous fat necrosis

Hormone Research

Volumn 65, Issue 6, 2006, Pages 289-294

  Alos, Nathalie ^a   Eugène, Dardye ^a   Fillion, Marc ^a   Powell, Julie ^a   Kokta, Victor ^a   Chabot, Gilles ^a  

^a UNIVERSITY OF MONTREAL   (Canada)

Author keywords

Hypercalcemia; Newborn; Pamidronate; Subcutaneous fat necrosis

Indexed keywords

CALCITRIOL; CALCIUM ION; FUROSEMIDE; PAMIDRONIC ACID;

ANAMNESIS; ARTICLE; CALCIUM INTAKE; CALCIUM URINE LEVEL; CASE REPORT; CLINICAL FEATURE; CREATININE URINE LEVEL; DIET RESTRICTION; DISEASE SEVERITY; FAT NECROSIS; FEMALE; FLUID THERAPY; HUMAN; HYPERCALCEMIA; KIDNEY CALCIFICATION; LABORATORY TEST; LOW DRUG DOSE; MALE; NEWBORN; NEWBORN DISEASE; PRIORITY JOURNAL; SKIN DEFECT; SUBCUTANEOUS FAT DISORDER;

EID: 33745029826     PISSN: 03010163     EISSN: None     Source Type: Journal    
DOI: 10.1159/000092602     Document Type: Article

References (19)

1. Gu LL, Daneman A, Binet A, Kooh SW: Nephrocalcinosis and nephrolithiasis due to subcutaneous fat necrosis with hypercalcemia in two full-term asphyxiated neonates: sonographic findings. Pediatr Radiol 1995;25:142-144.
2. Finne PH, Sanderud J, Aksnes L, Bratlid D, Aarskog D: Hypercalcemia with increased and unregulated 1,25-dihydroxyvitamin D production in a neonate with subcutaneous fat necrosis. J Pediatr 1988;112:792-794.
3. Cook JS, Stone MS, Hansen JR: Hypercalcemia in association with subcutaneous fat necrosis of the newborn: studies of calcium-regulating hormones. Pediatrics 1992;90(Pt 1):93-96.
4. Khan N, Licata A, Rogers D: Intravenous bisphosphonate for hypercalcemia accompanying subcutaneous fat necrosis: a novel treatment approach. Clin Pediatr (Phila) 2001;40:217-219.
5. Sargent JD, Stukel TA, Kresel J, Klein RZ: Normal values for random urinary calcium to creatinine ratios in infancy. J Pediatr 1993;123:393-397.
6. Plotkin H, Rauch F, Bishop NJ, Montpetit K, Ruck-Gibis J, Travers R, Glorieux FH: Pamidronate treatment of severe osteogenesis imperfecta in children under 3 years of age. J Clin Endocrinol Metab 2000;85:1846-1850.
7. Glover MT, Catterall MD, Atherton DJ: Subcutaneous fat necrosis in two infants after hypothermic cardiac surgery. Pediatr Dermatol 1991;8:210-212.
8. Tran JT, Sheth AP: Complications of subcutaneous fat necrosis of the newborn: a case report and review of the literature. Pediatr Dermatol 2003;20:257-261.
9. Balazs M: Subcutaneous fat necrosis of the newborn with emphasis on ultrastructural studies. Int J Dermatol 1987;26:227-230.
10. Norwood-Galloway A, Lebwohl M, Phelps RG, Raucher H: Subcutaneous fat necrosis of the newborn with hypercalcemia. J Am Acad Dermatol 1987;16(Pt 2):435-439.
11. Dudink J, Walther FJ, Beekman RP: Subcutaneous fat necrosis of the newborn: hypercalcaemia with hepatic and atrial myocardial calcification. Arch Dis Child Fetal Neonatal Ed 2003;88:F343-F345.
12. Drut R, Drut RM, Greco MA: Massive myocardial calcification in the perinatal period. Pediatr Dev Pathol 1998;1:366-374.
13. Kruse K, Irle U, Uhlig R: Elevated 1,25-dihydroxyvitamin D serum concentrations in infants with subcutaneous fat necrosis. J Pediatr 1993;122:460-463.
14. Sabokbar A, Pandey R, Athanasou NA: The effect of particle size and electrical charge on macrophage-osteoclast differentiation and bone resorption. J Mater Sci Mater Med 2003;14:731-738.
15. Cranefield DJ, Odd DE, Harding JE, Teele RL: High incidence of nephrocalcinosis in extremely preterm infants treated with dexamethasone. Pediatr Radiol 2004;34:138-142.
16. Alon US, Scagliotti D, Carola RE: Nephrocalcinosis and nephrolithiasis in infants with congestive heart failure treated with furosemide. J Pediatr 1994;125:149-151.
17. Bachrach LK, Lum CK: Etidronate in subcutaneous fat necrosis of the newborn. J Pediatr 1999;135:530-531.
18. Rice AM, Rivkees SA: Etidronate therapy for hypercalcemia in subcutaneous fat necrosis of the newborn. J Pediatr 1999;134:349-351.
19. Ezgu FS, Buyan N, Gunduz M, Tumer L, Okur I, Hasanoglu A: Vitamin D intoxication and hypercalcaemia in an infant treated with pamidronate infusions. Eur J Pediatr 2004;163:163-165.